Brookfield Corp’s Idexx Laboratories IDXX Stock Holding History

Brookfield Corp’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-37,393	Closed	-$18.7M	–	676
2023 Q1	$18.7M	Buy	37,393 +27,651	+284%	+$13.2M	0.07%	107
2022 Q4	$3.97M	Buy	9,742 +7,074	+265%	+$2.75M	0.01%	298
2022 Q3	$869K	Sell	2,668 -8,567	-76%	-$3.15M	﹤0.01%	548
2022 Q2	$3.94M	Buy	+11,235	New	+$4.58M	0.02%	297
2021 Q1	–	Sell	-1,659	Closed	-$829K	–	504
2020 Q4	$829K	Buy	+1,659	New	+$742K	﹤0.01%	388

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Brookfield Corp's IDXX Position: Q2 2023 in Review

Brookfield Corp sold out of Idexx Laboratories (IDXX) in Q2 2023, closing a stake of 37,393 shares — an estimated $18.7M sold.

Brookfield Corp first reported a position in IDXX in Q4 2020 and held it in 5 quarters. The position peaked at $18.7M in Q1 2023. 1,068 funds tracked by Wall St. Rank hold IDXX as of Q2 2023.

Brookfield Corp reported no remaining Idexx Laboratories position as of Q2 2023 after selling out during the quarter.
Brookfield Corp sold 37,393 Idexx Laboratories shares in Q2 2023, an estimated $18.7M.
Brookfield Corp first reported a position in Idexx Laboratories in Q4 2020 and held it in 5 quarters.
Brookfield Corp's Idexx Laboratories position peaked at $18.7M in Q1 2023.
1,068 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2023.

Based on Brookfield Corp's 13F filing for Q2 2023, filed 14 Aug 2023.